A cost-benefit analysis of genetic screening test for breast cancer in Iran
Số trang: 9
Loại file: pdf
Dung lượng: 1.32 MB
Lượt xem: 12
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
This study aimed to evaluate the implementation of the population- and family history (FH) -based screening for BReast CAncer (BRCA) in Iran, a country where less than 10% of breast cancer cases are attributable to a gene mutation.
Nội dung trích xuất từ tài liệu:
A cost-benefit analysis of genetic screening test for breast cancer in Iran
Nội dung trích xuất từ tài liệu:
A cost-benefit analysis of genetic screening test for breast cancer in Iran
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Breast cancer BRCA1 protein BRCA2 protein Cost-benefit analysis Willingness to pay Economic evaluationGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 167 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 139 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 109 0 0 -
12 trang 87 0 0
-
19 trang 72 0 0
-
17 trang 60 0 0
-
9 trang 35 0 0
-
11 trang 35 0 0
-
12 trang 33 0 0